🟢 Medpace Holdings is trading 7.8% up in pre-market — cause remains unconfirmed

Medpace Holdings is trading 7.8% up in pre-market at $668.74, with the cause of the move unconfirmed.

• The price compares with the October 5 close of $620.51.
• No confirmed company-specific announcement explains the October 6 pre-market move; the next scheduled earnings report is October 21.
• Broader markets are modestly higher, but supplied index moves are below 0.5% and do not establish a clear market-wide explanation.